Interpreting Abnormal Liver Blood Tests & the Diagnosis and Management of MASLD/MASH in Primary Care- Dr Kevin Fernando

MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease) is rapidly emerging as a major clinical priority, closely tied to diabetes, obesity, and dyslipidaemia. Primary care clinicians are key to early detection, risk stratification, and long-term management.

Your Learning Agenda:

• Clinical interpretation of abnormal LBTs in context
• MASLD vs MASH: what the new terminology means for primary care
• Using FIB-4 and other tools for fibrosis risk stratification
• Management strategies including lifestyle and pharmacological options
• The role of lipid-lowering therapies including statins, ezetimibe, bempedoic acid, and inclisiran in cardiometabolic risk reduction

Please note that only the session with Dr. Fernando will be recorded.
A CPD certificate will be issued to all attendees. Slides will be shared with attendees within 7 days of the webinar

The Teams link to join the event within the e-ticket will be sent to the email address you used to register.

Please check your spam or junk folder in case it doesn’t appear in your inbox

Meet the Speaker: Dr.Kevin Fernando

Dr Kevin Fernando is a portfolio GP based near Edinburgh, working across NHS and private sectors. He is a Fellow of the RCGP, RCPE, and the Academy of Medical Educators, and holds an MSc in Diabetes (Distinction). He serves as Content Advisor for WebMD Medscape (UK & Global), is an Honorary Clinical Reader at the University of Dundee, and co-founded CVRMUK to support person-centred CVRM care and education. Kevin is a nationally and internationally recognised speaker and medical writer, with a focus on type 2 diabetes, CVRM, and the interpretation of abnormal blood tests in primary care. He regularly contributes to peer-reviewed journals, clinical summaries, and congress highlights tailored for primary care professionals.